11349720

Source:http://linkedlifedata.com/resource/pubmed/id/11349720

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005767, umls-concept:C0009647, umls-concept:C0010825, umls-concept:C0087111, umls-concept:C0286079, umls-concept:C1504389, umls-concept:C1515895
pubmed:issue	7
pubmed:dateCreated	2001-5-14
pubmed:abstractText	Cidofovir (CDV) is a nucleotide analogue with proven in vitro effects against cytomegalovirus (CMV) and adenovirus and has been successfully used in the treatment of CMV retinitis in AIDS patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cytosine, http://linkedlifedata.com/resource/pubmed/chemical/Myeloablative Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Viral Matrix Proteins, http://linkedlifedata.com/resource/pubmed/chemical/cidofovir, http://linkedlifedata.com/resource/pubmed/chemical/cytomegalovirus matrix protein 65kDa
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0041-1337
pubmed:author	pubmed-author:BandoAA, pubmed-author:BornhäuserMM, pubmed-author:EhningerGG, pubmed-author:Freiberg-RichterJJ, pubmed-author:GeisslerGG, pubmed-author:HelwigAA, pubmed-author:PlatzbeckerUU, pubmed-author:PlettigRR, pubmed-author:RethwilmAA, pubmed-author:SchulerUU, pubmed-author:ThiedeCC
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	71
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	880-5
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:11349720-Adult, pubmed-meshheading:11349720-Antigens, Viral, pubmed-meshheading:11349720-Antiviral Agents, pubmed-meshheading:11349720-Cytomegalovirus, pubmed-meshheading:11349720-Cytomegalovirus Infections, pubmed-meshheading:11349720-Cytosine, pubmed-meshheading:11349720-Dose-Response Relationship, Drug, pubmed-meshheading:11349720-Feasibility Studies, pubmed-meshheading:11349720-Female, pubmed-meshheading:11349720-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11349720-Humans, pubmed-meshheading:11349720-Incidence, pubmed-meshheading:11349720-Male, pubmed-meshheading:11349720-Middle Aged, pubmed-meshheading:11349720-Mycoses, pubmed-meshheading:11349720-Myeloablative Agonists, pubmed-meshheading:11349720-Organophosphorus Compounds, pubmed-meshheading:11349720-Phosphonic Acids, pubmed-meshheading:11349720-Phosphoproteins, pubmed-meshheading:11349720-Preventive Medicine, pubmed-meshheading:11349720-Prospective Studies, pubmed-meshheading:11349720-Transplantation Conditioning, pubmed-meshheading:11349720-Viral Matrix Proteins
pubmed:year	2001
pubmed:articleTitle	Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
pubmed:affiliation	Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany. platzbecker@oncocenter.de
pubmed:publicationType	Journal Article